SPIA
VNDA icon

Steward Partners Investment Advisory’s Vanda Pharmaceuticals VNDA Stock Holding History

Steward Partners Investment Advisory’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55K Buy
+369
New +$2.85K ﹤0.01% 3985
2020
Q1 		– Sell
-1
Closed – – 2712
2019
Q4 		$0 Sell
1
-1
-50% -$15 ﹤0.01% 2752
2019
Q3 		$0 Hold
2
– – ﹤0.01% 2777
2019
Q2 		$0 Buy
+2
New +$32 ﹤0.01% 2695

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's VNDA Position: Q1 2026 in Review

Steward Partners Investment Advisory opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 369 shares worth $2.55K. The stake represents ﹤0.01% of the portfolio and ranks #3985 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in VNDA as recently as Q4 2019.

Steward Partners Investment Advisory first reported a position in VNDA in Q2 2019 and has held it in 4 quarters since. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Steward Partners Investment Advisory held 369 shares of Vanda Pharmaceuticals worth $2.55K as of Q1 2026.
  • Vanda Pharmaceuticals was a new Steward Partners Investment Advisory position in Q1 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3985 holding.
  • Steward Partners Investment Advisory first reported a position in Vanda Pharmaceuticals in Q2 2019 and has held it in 4 quarters since.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.